Måndag 12 Maj | 02:31:56 Europe / Stockholm

Kalender

Est. tid*
2025-07-28 18:00 Kvartalsrapport 2025-Q2
2025-05-07 - X-dag ordinarie utdelning EL 3.95 EUR
2025-04-30 - Extra Bolagsstämma
2025-04-30 - Årsstämma
2025-02-12 - Bokslutskommuniké 2024
2024-07-25 - Kvartalsrapport 2024-Q2
2024-05-03 - X-dag ordinarie utdelning EL 3.95 EUR
2024-04-30 - Extra Bolagsstämma
2024-04-30 - Årsstämma
2024-02-14 - Bokslutskommuniké 2023
2023-07-26 - Kvartalsrapport 2023-Q2
2023-05-22 - X-dag ordinarie utdelning EL 3.23 EUR
2023-05-17 - Extra Bolagsstämma
2023-05-17 - Årsstämma
2023-03-10 - Bokslutskommuniké 2022
2022-07-29 - Kvartalsrapport 2022-Q2
2022-05-30 - X-dag ordinarie utdelning EL 2.51 EUR
2022-05-25 - Extra Bolagsstämma
2022-05-25 - Årsstämma
2022-03-11 - Bokslutskommuniké 2021
2021-07-30 - Kvartalsrapport 2021-Q2
2021-05-28 - X-dag halvårsutdelning EL 1.08
2021-05-21 - Extra Bolagsstämma
2021-05-21 - Årsstämma
2021-03-12 - Bokslutskommuniké 2020
2020-12-23 - X-dag bonusutdelning EL 1.15
2020-06-25 - Extra Bolagsstämma
2020-06-25 - Årsstämma
2019-10-30 - Kvartalsrapport 2019-Q3
2025-02-03 08:00:00

EssilorLuxottica receives FDA clearance and EU certifications for Nuance Audio, making it available to consumers in the U.S. and Europe

Paris, France (3 February 2025) – EssilorLuxottica announced today that it has received clearance from the Food and Drug Administration (FDA) for its OTC Nuance Audio Glasses. The Group has simultaneously achieved the CE marking under the Medical Devices Regulation in the EU, alongside the development of an ISO Quality Management System certification dedicated to Hearing Aids, which will allow Nuance Audio to launch in Europe.

Paving the way for a disruptive new category in the med-tech space, Nuance Audio Hearing Aid Software is the first FDA cleared, preset Software as Medical Device (SaMD) in the U.S. It delivers a groundbreaking open-ear hearing solution seamlessly integrated into a pair of stylish smart glasses. After decades of adoption barriers ranging from comfort to visibility, consumers will finally be able to see clearly and hear clearly with a single product that is both beautiful and highly functional.

Nuance Audio will be available for purchase in the U.S. beginning in Q1. In the first half of 2025, it will be available in certain European countries, including France, Germany and UK, starting progressively from Italy in Q1, in parallel with U.S. market.

As part of EssilorLuxottica ’s open business model, the Group will leverage its extensive retail network, while also engaging both traditional audiology practices and optical wholesale customers to make this technology accessible to consumers wherever possible.

“Two years ago, we set out to create a first-of-its-kind product that would change the way people see and hear. We didn’t just aim to combine two medical devices – we created an entirely new smart glasses form factor to support the two human senses we depend on the most. It is not only groundbreaking, but also incredibly accessible. We’re pleased now to turn our focus to getting this life-changing technology into the hands of people around the world who truly need it,” said Francesco Milleri, Chairman and CEO of EssilorLuxottica.

The global hearing solutions market remains underserved, much like the vision market decades ago, where consumers are often hesitant to wear corrective devices due to factors such as stigma, discomfort, cost, and limited accessibility. Nuance Audio seeks to overcome these barriers, which have hindered the widespread adoption of traditional hearing aids. With the introduction of Nuance Audio Glasses, the company aims to meet the needs of approximately 1.25 billion1 people worldwide who experience mild to moderate hearing loss.

Notes:
1 World Health Organization, World Report on Hearing, 2021, p. 40.